Inhibition of Dopamine Transporter Activity by G Protein βγ Subunits

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Garcia Olivares, Jennie ^a   Torres Salazar, Delany ^a   Owens, William A ^b   Baust, Tracy ^a   Siderovski, David P ^c   Amara, Susan G ^a   Zhu, Jun ^d   Daws, Lynette C ^b   Torres, Gonzalo E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE);

AMPEROMETRY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; XENOPUS LAEVIS;

ANIMALS; BIOTINYLATION; BRAIN; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTATHIONE TRANSFERASE; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; GUANOSINE TRIPHOSPHATE; HEK293 CELLS; HOMEOSTASIS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; OOCYTES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SYNAPTOSOMES; XENOPUS LAEVIS;

EID: 84875460411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059788     Document Type: Article

References (35)

1. Gainetdinov RR, Sotnikova TD, Caron MG, (2002) Monoamine transporter pharmacology and mutant mice. Trends Pharmacol Sci 23: 367-373.
2. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, et al. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95: 4029-4034.
3. Zahniser NR, Sorkin A, (2004) Rapid regulation of the dopamine transporter: role in stimulant addiction. Neuropharmacology 47Suppl 1: 80-91.
4. Foster JD, Cervinski MA, Gorentla BK, Vaughan RA, (2006) Regulation of the dopamine transporter by phosphorylation. Handb Exp Pharmacol 175: 197-214.
5. Eriksen J, Jorgensen TN, Gether U, (2011) Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J Neurochem 113: 27-41.
6. Sager JJ, Torres GE, (2011) Proteins interacting with monoamine transporters: current state and future challenges. Biochemistry 50: 7295-7310.
7. Egaña LA, Cuevas RA, Baust TB, Parra LA, Leak RK, et al. (2009) Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci 29: 4592-4604.
8. Ahnert-Hilger G, Nurnberg B, Exner T, Schafer T, Jahn R, (1998) The heterotrimeric G protein Go2 regulates catecholamine uptake by secretory vesicles. EMBO J 17: 406-413.
9. Brunk I, Blex C, Rachakonda S, Holtje M, Winter S, et al. (2006) The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake. J Biol Chem 281: 33373-33385.
10. Ahnert-Hilger G, Schafer T, Spicher K, Grund C, Schultz G, et al. (1994) Detection of G-protein heterotrimers on large dense core and small synaptic vesicles of neuroendocrine and neuronal cells. Eur J Cell Biol 65: 26-28.
11. Carneiro AM, Ingram SL, Beaulieu JM, Sweeney A, Amara SG, et al. (2002) The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J Neurosci 22: 7045-7054.
12. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, et al. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278: 2731-2739.
13. Walev I, Bhakdi SC, Hofmann F, Djonder N, Valeva et al, (2001) Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci USA 98: 3185-3190.
14. Zhu J, Mactutus CF, Wallace DR, Booze RM, (2009) HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. J Pharmacol Exp Ther 329: 1071-1083.
15. Zahniser NR, Larson GA, Gerhardt GA, (1999) In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther 289: 266-277.
16. Callaghan PD, Irvine RJ, Daws LC, (2005) Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int 47: 350-361.
17. Clapham DE, Neer EJ, (1997) G protein beta gamma subunits. Ann Rev Pharmacol 37: 167-203.
18. Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, et al. (1998) Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280: 1271-1274.
19. Yevenes GE, Peoples RW, Tapia JC, Parodi J, Soto X, et al. (2003) Modulation of glycine-activated ion channel function by G-protein betagamma subunits. Nat Neurosci 6: 819-824.
20. Goubaeva F, Ghosh M, Malik S, Yang J, Hinkle PM, et al. (2003) Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J Biol Chem 278: 19634-19641.
21. Smrcka AV, (2008) G protein betagamma subunits: central mediators of G protein-coupled receptor signaling. Cell Mol Life Sci 65: 2191-2214.
22. Zhao Y, Fang Q, Straub SG, Lindau M, Sharp GW, (2010) Noradrenaline inhibits exocytosis via the G protein betagamma subunit and refilling of the readily releasable granule pool via the alpha(i1/2) subunit. J Physiol 588: 3485-3498.
23. Blumer JB, Smrcka AV, Lanier SM, (2007) Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol Therapeut 113: 488-506.
24. Cass WA, Gerhardt GA, (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 176: 259-263.
25. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71: 1222-1232.
26. Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, et al. (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J 26: 2127-2136.
27. Smrcka AV, Lehmann DM, Dessal AL, (2008) G protein betagamma subunits as targets for small molecule therapeutic development. Comb Chem High Throughput Screen 11: 382-395.
28. Zhang XL, Upreti C, Stanton PK, (2011) Gbetagamma and the C Terminus of SNAP-25 Are Necessary for Long-Term Depression of Transmitter Release. PLoS One 6: e20500.
29. McCudden CR, Hains MD, Kimple RJ, Siderovski DP, Willard FS, (2005) G-protein signaling: back to the future. Cell Mol Life Sci 62: 551-577.
30. Zamponi GW, (2001) Determinants of G protein inhibition of presynaptic calcium channels. Cell Biochem Biophys 34: 79-94.
31. Jarvis SE, Magga JM, Beedle AM, Braun JE, Zamponi GW, (2000) G protein modulation of N-type calcium channels is facilitated by physical interactions between syntaxin 1A and Gbetagamma. J Biol Chem 275: 6388-6394.
32. Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, et al. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol 74: 1101-1108.
33. Carvelli L, Blakely RD, DeFelice LJ, (2008) Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci USA 105: 14192-14197.
34. Cervinski MA, Foster JD, Vaughan RA, (2010) Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience 170: 408-416.
35. Lin Z, Canales JJ, Bjorgvinsson T, Thomsen M, Qu H, et al. (2011) Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci 98: 1-46.